Suraj Kalia
Stock Analyst at Oppenheimer
(3.06)
# 2,161
Out of 5,056 analysts
84
Total ratings
45.07%
Success rate
11.83%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $84.04 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $28.40 | +111.27% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $13.60 | +61.76% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $117.07 | +28.13% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $33.16 | +35.71% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $11.86 | +93.93% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $169.67 | -29.27% | 6 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $44.83 | -28.62% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $86.48 | +7.54% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $130.00 | - | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $4.60 | +117.39% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $4.62 | +181.39% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $67.75 | +99.26% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $246.22 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $23.19 | +29.37% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $1.37 | +14,498.54% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $71.02 | +36.58% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $24.03 | +16.52% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.01 | +123.88% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.20 | +1,233.33% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $546.77 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $1.86 | +35,383.87% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $83.57 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $3.31 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $18.15 | +450.96% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $60.17 | - | 5 | Sep 12, 2018 |
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $84.04
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $28.40
Upside: +111.27%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $13.60
Upside: +61.76%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $117.07
Upside: +28.13%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $33.16
Upside: +35.71%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $11.86
Upside: +93.93%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $169.67
Upside: -29.27%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $44.83
Upside: -28.62%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $86.48
Upside: +7.54%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $130.00
Upside: -
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.60
Upside: +117.39%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $4.62
Upside: +181.39%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $67.75
Upside: +99.26%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $246.22
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $23.19
Upside: +29.37%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $1.37
Upside: +14,498.54%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $71.02
Upside: +36.58%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $24.03
Upside: +16.52%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.01
Upside: +123.88%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.20
Upside: +1,233.33%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $546.77
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $1.86
Upside: +35,383.87%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $83.57
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $3.31
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $18.15
Upside: +450.96%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $60.17
Upside: -